[HTML][HTML] The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot

…, D Brites, A Ross, G Goig, M Reinhard… - Nature …, 2023 - nature.com
Multidrug-resistant tuberculosis (MDR-TB) is among the most frequent causes of death due
to antimicrobial resistance. Although only 3% of global TB cases are MDR, geographical …

Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis

…, L Jugheli, N Adamia, A Trauner, M Reinhard… - Nature medicine, 2021 - nature.com
Multidrug-resistant tuberculosis (MDR-TB) accounts for one third of the annual deaths due
to antimicrobial resistance 1 . Drug resistance-conferring mutations frequently cause fitness …

Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis

…, N Blöchliger, R Hömke, M Reinhard… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Whole-genome sequencing allows rapid detection of drug-resistant Mycobacterium tuberculosis
isolates. However, the availability of high-quality data linking quantitative phenotypic …

[HTML][HTML] Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development

…, M Kato-Maeda, J Feldmann, M Reinhard… - PLoS one, 2019 - journals.plos.org
The Mycobacterium tuberculosis complex (MTBC) causes tuberculosis (TB) in humans and
various other mammals. The human-adapted members of the MTBC comprise seven …

[HTML][HTML] Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a …

…, J Daniels, A Reuter, S Borrell, M Reinhard… - The Lancet …, 2023 - thelancet.com
Background Experimental data show that drug-resistance-conferring mutations are often
associated with a decrease in the replicative fitness of bacteria in vitro, and that this fitness cost …

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

…, K Kawkitinarong, M Reinhard… - The Lancet Infectious …, 2019 - thelancet.com
Background Drug resistance is a challenge for the global control of tuberculosis. We
examined mortality in patients with tuberculosis from high-burden countries, according to …

The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis

…, A Ross, L Kamwela, M Reinhard… - Molecular biology …, 2020 - academic.oup.com
Fluoroquinolones (FQ) form the backbone in experimental treatment regimens against drug-susceptible
tuberculosis. However, little is known on whether the genetic variation present in …

[HTML][HTML] Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre …

…, M Ballif, C Loiseau, S Borrell, M Reinhard… - The Lancet …, 2021 - thelancet.com
Background Drug resistance threatens global tuberculosis control. We aimed to examine
mortality in patients with tuberculosis from high-burden countries, according to concordance or …

[HTML][HTML] Local adaptation in populations of Mycobacterium tuberculosis endemic to the Indian Ocean Rim

…, N Rakotosamimanana, V Rasolofo, M Reinhard… - …, 2021 - ncbi.nlm.nih.gov
Background: Lineage 1 (L1) and 3 (L3) are two lineages of the Mycobacterium tuberculosis
complex (MTBC) causing tuberculosis (TB) in humans. L1 and L3 are prevalent around the …

Whole-genome sequencing has the potential to improve treatment for rifampicin-resistant tuberculosis in high-burden settings: a retrospective cohort study

…, MP Nicol, S Borrell, M Reinhard… - Journal of clinical …, 2022 - Am Soc Microbiol
ABSTRACT Treatment of multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB),
although improved in recent years with shorter, more tolerable regimens, remains largely …